Related Experiment Videos
High expression of cyclooxygenase-2 in macrophages of human colonic adenoma
1First Department of Internal Medicine, Saitama Medical Center, Saitama Medical School, Saitama, Japan. bam@saitama-med.ac.jp
Abstract:
Cyclooxygenase (COX)-2 is a possible molecular target for suppression of colon carcinogenesis by non-steroidal anti-inflammatory drugs (NSAIDs). However, the expression of COX-2 in human colonic tumors during the adenoma-carcinoma sequence has not been elucidated. In the present study, we examined immuno-histochemically the expression and localization of the COX-2 protein in human colonic adenomas and cancers. Twelve human colonic adenomas and 9 advanced cancers were studied. Immunoreactive COX-2 was predominantly and strongly expressed in sub-epithelial interstitial cells broadly present in the surface area of adenomas. The staining pattern of macrophages was similar to that observed for COX-2 in adenomas. Adjacent normal colonic mucosa was negative for COX-2 expression. In contrast, COX-2 was relatively weakly expressed in both tumor cells and interstitial cells in advanced colon cancers. In conclusion, the target of NSAIDs in preventing colon carcinogenesis may be the COX-2 expressed in interstitial cells, possibly macrophages, of colonic adenomas.
Insights
Non-steroidal anti-inflammatory drugs (NSAIDs) may target cyclooxygenase-2 (COX-2) in colon adenomas. This study found COX-2 primarily in interstitial cells of adenomas, not advanced cancers, suggesting a key role in early colon carcinogenesis.
Area of Science:
- Oncology
- Gastroenterology
- Molecular Biology
Background:
- Cyclooxygenase-2 (COX-2) is implicated in colon cancer development.
- The precise role and localization of COX-2 during colon carcinogenesis remain unclear.
- Non-steroidal anti-inflammatory drugs (NSAIDs) are known to target COX-2.
Purpose of the Study:
- To investigate the expression and localization of COX-2 protein in human colonic adenomas and cancers.
- To elucidate the role of COX-2 in the adenoma-carcinoma sequence.
- To identify potential molecular targets for NSAID-mediated chemoprevention.
Main Methods:
- Immunohistochemical analysis of COX-2 protein expression.
- Study of 12 human colonic adenomas and 9 advanced colon cancers.
- Comparison of COX-2 staining patterns in normal mucosa, adenomas, and cancers.
Main Results:
- COX-2 was strongly expressed in sub-epithelial interstitial cells, potentially macrophages, in adenomas.
- Normal colonic mucosa showed no COX-2 expression.
- COX-2 expression was weaker in both tumor and interstitial cells of advanced colon cancers compared to adenomas.
Conclusions:
- The primary target of NSAIDs in preventing colon cancer may be COX-2 expressed in the interstitial cells, possibly macrophages, of colonic adenomas.
- COX-2 expression patterns differ significantly between adenomas and advanced cancers.
- Understanding COX-2 localization is crucial for developing effective colon cancer chemoprevention strategies.